Changes in FKBP5 expression and memory functions during cognitive-behavioral therapy in posttraumatic stress...

Area of Science:

• Neuroscience
• Psychiatry
• Molecular Biology

Background:

• Posttraumatic stress disorder (PTSD) is associated with memory impairments, but the effects of psychotherapy on memory and related gene expression remain unclear.
• The hippocampus is crucial for memory, and its function may be altered in PTSD patients.

Purpose of the Study:

• To investigate the impact of cognitive behavioral therapy (CBT) on memory functions in patients with PTSD.
• To explore changes in blood FK506 binding protein (FKBP5) mRNA expression following CBT in PTSD patients.
• To determine the relationship between FKBP5 expression and memory performance improvements.

Main Methods:

• Assessed memory performance in PTSD patients (n=20) and trauma-exposed controls (n=20) using the Wechsler Memory Scale-Revised (WAIS-R) and a paired associates learning (PAL) test.
• Measured blood FKBP5 mRNA expression levels before and after CBT in PTSD patients.
• Correlated memory test results with FKBP5 mRNA expression changes.

Main Results:

• PTSD patients exhibited significant impairments in delayed recall, attention/concentration, and PAL before CBT compared to controls.
• CBT treatment led to significant improvements in these memory functions.
• Improved performance on the PAL test was positively correlated with increased blood FKBP5 mRNA expression.

Conclusions:

• Cognitive behavioral therapy (CBT) effectively ameliorates memory dysfunctions in patients with posttraumatic stress disorder (PTSD).
• Elevated FKBP5 mRNA expression during CBT is associated with enhanced associative memory, potentially linked to hippocampal function.
• FKBP5 may serve as a molecular marker for memory recovery in PTSD patients undergoing psychotherapy.